Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details)

v3.24.2.u1
Summary of Significant Accounting Policies - Summary of Consolidated Subsidiaries (Details)
12 Months Ended
Mar. 31, 2024
Virax Biolabs Group Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction Cayman Island
Incorporation Date Sep. 02, 2021
Virax Biolabs (UK) Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction United Kingdom
Incorporation Date Aug. 19, 2021
Ownership 100.00%
Virax Biolabs Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction Hong Kong
Incorporation Date Apr. 14, 2020
Ownership 100.00%
Virax Immune T- Cell Medical Device Company Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction Hong Kong
Incorporation Date Jan. 16, 2017
Ownership 100.00%
Virax Biolabs Pte. Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction Singapore
Incorporation Date May 04, 2013
Logico Bioproducts Corp.  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction BVI
Incorporation Date Jan. 21, 2011
Ownership 95.54%
Shanghai Xitu Consulting Co., Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction PRC
Incorporation Date Oct. 27, 2017
Ownership 95.54%
Virax Biolabs USA Management, Inc.  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction USA
Incorporation Date Aug. 01, 2022
Ownership 100.00%
Virax Biolabs Group Holdings Ltd  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction United Kingdom
Incorporation Date Feb. 22, 2023
Ownership 100.00%
Virax Biolabs FZ-LLC  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction United Arab Emirates
Incorporation Date Apr. 18, 2023
Ownership 100.00%
Virax Biolabs Trading B.V.  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction Netherlands
Incorporation Date Aug. 04, 2023
Ownership 100.00%
Virax Biolabs UK Operating Limited  
Disclosure of reclassifications or changes in presentation [line items]  
Jurisdiction United Kingdom
Incorporation Date Nov. 07, 2023
Ownership 100.00%